BMS-336 (Bristol-Myers Squibb)

N/A

Report date: 2025/03/14 16:43:05
NME

Base Information

Drug NameBMS-336 (Bristol-Myers Squibb)
Drug Alias NameROR-gamma t inhibitor (Bristol-Myers Squibb/University of British Columbia)retinoic acid receptor-related orphan receptor gamma t inhibitor (Bristol-Myers Squibb/University of British Columbia)BMS-336
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma antagonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of British ColumbiaBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A